Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

AD
News
Efficacy of Targeted Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: A Network Meta-Analysis
06/15/2024
Riya Gandhi, MA, Associate Editor
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in SKIN The Journal of Cutaneous Medicine, has compared the efficacy of various targeted systemic monotherapies for moderate-to-severe atopic dermatitis, including the emerging biologic lebrikizumab.
A recent study, published in...
06/15/2024
The Dermatologist

Advertisement

medical bill
News
Identifying Candidates for Systemic Therapy in Atopic Dermatitis: A Practical Checklist
06/14/2024
Riya Gandhi, MA, Associate Editor
A novel checklist, known as the, “When to Start Systemic Therapy Checklist,” has been developed to assist dermatology providers in determining when to initiate systemic therapy for patients with atopic dermatitis.
A novel checklist, known as the, “When to Start Systemic Therapy Checklist,” has been developed to assist dermatology providers in determining when to initiate systemic therapy for patients with atopic dermatitis.
A novel checklist, known as the,...
06/14/2024
The Dermatologist
AD
News
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis
06/13/2024
Riya Gandhi, MA, Associate Editor
A recent study has shed light on the efficacy and safety of ruxolitinib cream among adolescents grappling with atopic dermatitis.
A recent study has shed light on the efficacy and safety of ruxolitinib cream among adolescents grappling with atopic dermatitis.
A recent study has shed light on...
06/13/2024
The Dermatologist
psoriatic arthritis
News
Anti-Inflammatory Diet and Fecal Microbiota Transplant in Psoriatic Arthritis
06/13/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to explore the roles of anti-inflammatory diets and fecal microbiota transplant in PsA management.
Researchers aimed to explore the roles of anti-inflammatory diets and fecal microbiota transplant in PsA management.
Researchers aimed to explore the...
06/13/2024
The Dermatologist

Advertisement

psoriasis
News
Shared Biomarkers and Pathways in Psoriasis and Cervical Squamous Cell Carcinoma
06/13/2024
Jessica Garlewicz, Digital Managing Editor
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the GSE63514 CESC dataset from the Gene Expression Omnibus and combined 2 psoriasis datasets (GSE13355 and GSE14905) into a single comprehensive dataset after adjusting for batch effects.
Researchers utilized the...
06/13/2024
The Dermatologist
alopecia
News
SiSaf’s Bio-Courier Technology Achieves Clinical Success for Topical Alopecia Areata Treatment
06/12/2024
Riya Gandhi, MA, Associate Editor
SiSaf Ltd announced positive topline results from a phase II clinical trial of a licensee's topical treatment for mild to moderate alopecia areata (AA).
SiSaf Ltd announced positive topline results from a phase II clinical trial of a licensee's topical treatment for mild to moderate alopecia areata (AA).
SiSaf Ltd announced positive...
06/12/2024
The Dermatologist
Atopic dermatitis
News
Arcutis Presents Long-Term Data on Roflumilast Cream for Atopic Dermatitis
06/11/2024
Riya Gandhi, MA, Associate Editor
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia Areata, Vitiligo, and Eczema Conference, Arcutis Biotherapeutics, Inc., unveiled new findings from the INTEGUMENT-OLE long-term open-label study of roflumilast cream 0.15% for adults and children with atopic...
At the Revolutionizing Alopecia...
06/11/2024
The Dermatologist

Advertisement

News
Assessing Complications in Lip Augmentation With Dermal Fillers
06/06/2024
Lip augmentation through dermal filler injections has become increasingly popular as a noninvasive cosmetic procedure.
Lip augmentation through dermal filler injections has become increasingly popular as a noninvasive cosmetic procedure.
Lip augmentation through dermal...
06/06/2024
The Dermatologist
acne
News
Evolution of Acne Research Based on Top-Cited Articles
05/29/2024
Jessica Garlewicz, Digital Managing Editor
Researchers conducted a comprehensive search of the Web of Science database on August 8, 2023.
Researchers conducted a comprehensive search of the Web of Science database on August 8, 2023.
Researchers conducted a...
05/29/2024
The Dermatologist
skin cancer
News
Establishing a Novel Model for Studying Neural Invasion in Non-Melanoma Skin Cancer
05/15/2024
Jessica Garlewicz, Digital Managing Editor
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a 3-dimensional model of neural invasion in squamous cell carcinoma to better understand its underlying biologic mechanisms, which are still poorly understood.
Researchers aimed to develop a...
05/15/2024
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Melanoma Update: Highlights of research presented at ASCO and an update on vaccines trials.
03/06/2009
Mixed Melanoma Trial Results Point to Need for Tailored Studies Effective melanoma therapies may be inching forward, with a number of the new class of potential therapeutics in the pipeline entering Phase III trials, and researchers...
Mixed Melanoma Trial Results Point to Need for Tailored Studies Effective melanoma therapies may be inching forward, with a number of the new class of potential therapeutics in the pipeline entering Phase III trials, and researchers...
Mixed Melanoma Trial Results...
03/06/2009
The Dermatologist
HS lesions
Quiz
Trivia: Are Female Patients With HS At High Risk for Adverse Pregnancy Outcomes?
12/21/2021
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an independent risk factor for adverse pregnancy and maternal outcomes.
True or false: HS is an...
12/21/2021
The Dermatologist
Q&As
Q&A: Richard Brindle, MD, on the Efficacy of Antibiotics for Cellulitis
09/18/2019
Melissa Weiss, Associate Editor
In a systematic review, Richard Brindle, MD, and colleagues investigated whether certain antibiotics, routes of administration, and/or treatment duration affected treatment outcomes among patients with cellulitis. He discussed these findings...
In a systematic review, Richard Brindle, MD, and colleagues investigated whether certain antibiotics, routes of administration, and/or treatment duration affected treatment outcomes among patients with cellulitis. He discussed these findings...
In a systematic review, Richard...
09/18/2019
The Dermatologist
MOSAIC Fractional Laser System ‘Spray Paints’ Damaged Skin
09/22/2008
Said to be flexible and precise, the MOSAIC fractional laser system from Lutronic USA (Princeton Junction, NJ) is designed for a variety of aesthetic and dermatological applications, including scarring, sun-damaged skin and skin...
Said to be flexible and precise, the MOSAIC fractional laser system from Lutronic USA (Princeton Junction, NJ) is designed for a variety of aesthetic and dermatological applications, including scarring, sun-damaged skin and skin...
Said to be flexible and precise,...
09/22/2008
The Dermatologist
NRS Approved Features
Pop Quiz: Rosacea Research
02/11/2022
Rosacea is a common dermatologic condition affecting the face. New research aims to better understand the condition in order to improve diagnosis rates and patient care. Test your knowledge with this quiz series on recent research!
Rosacea is a common dermatologic condition affecting the face. New research aims to better understand the condition in order to improve diagnosis rates and patient care. Test your knowledge with this quiz series on recent research!
Rosacea is a common dermatologic...
02/11/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
Riya Gandhi, MA, Associate Editor
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA, Associate Editor
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA, Associate Editor
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA, Associate Editor
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
Jessica Garlewicz, Digital Managing Editor
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use